Abstract
The cellular transcription factor Brn-3a differentially regulates different human papilloma virus (HPV)-16 variants that are associated with different risks of progression to cervical carcinoma in infected humans. The upstream regulatory regions (URRs) of high- and intermediate-risk HPV-16 variants are activated by the cellular transcription factor Brn-3a, whereas the URR of a low-risk HPV-16 variant is not. In this study, we show in transfection assays that Brn-3a and the smoking-related substance nicotine produce stronger responsiveness of the URR of the low- and high-risk variants than with either factor alone, but not the intermediate-risk variant. We determined that this synergistic activity of Brn-3a/nicotine is due to two nucleotide differences in the URR, crucial for oncogenic E6/E7 transactivation. Mutant constructs in which the nucleotide residues were substituted alter Brn-3a/nicotine responsiveness. Importantly, women smokers with high levels of Brn-3a infected with low- or high-risk HPV-16 variants have augmented E6 levels, and were more frequently diagnosed with higher grades of cervical intraepithelial neoplasia (CIN) and cancer, as compared with non-smokers who were infected with similar variants and expressed similar levels of Brn-3a. Therefore, this study defines the specific interplay between the cellular transactivator Brn-3a, the environmental smoking-related substance nicotine and specific HPV variants in cervical carcinogenesis, and thus helps to explain why some women are susceptible to rapid CIN progression and cancer and others are not.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- URR:
-
upstream regulatory region
- CIN:
-
cervical intraepithelial neoplasia
References
Anthony SG, Trung NT, Anna T, Paul WD, Pär S, Juni P et al. (2006). Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev 15: 2141–2142.
Bible JM, Mant C, Best JM, Kell B, Starkey WG, Shanti RG et al. (2000). Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 81: 1517–1527.
Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 85: 796–802.
Burghardt E, Girardi F, Lahousen M, Pickel H, Tamussino K . (1991). Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer 15: 1037–1045.
Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PG, Durst M et al. (1987). Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer and by viral E2 tranactivation and repressor gene products: implication of cervical carcinogenesis. (1987). EMBO J 6: 3745–3753.
Cox MF, Meanwell CA, Maitland NJ, Blackledge G, Scully C, Jordan JA . (1986). Human papilloma virus type-16 homologous DNA in normal ectocervix. Lancet 2: 157–158.
Dasgupta P, Kinkade R, Joshi B, DeCook C, Haura E, Chellappan S et al. (2006a). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103: 6332–6337.
Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E et al. (2006b). Nicotine induces cell proliferation by β-arrestin-mediated activation of Src and Rb–Raf-1 pathways. Clin Invest 116: 2208–2217.
Harkness P, Millar N . (2002). Changes in conformation and subcellular distribution of nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. J Neurosci 22: 10172–10181.
Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder E . (1988). Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 15: 910–913.
Lane D, Gray EA, Mathur RS, Mathur SP . (2005). Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am J Reprod Immunol 53: 153–158.
Lee SA, Ndisang D, Patel C, Dennis J, Faulkes D, D'Arrigo C et al. (2005). Expression of Brb-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of HSP-27 promoter. Cancer Res 65: 3072–3080.
Lillycrop KA, Budhram-Mahadeo VS, Lakin N, Terrenghi G, Wood JN, Polak JM et al. (1992). A novel POU family transcription factor I closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res 20: 5093–5096.
McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM . (1992). Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1: 125–129.
Miller AB . (2001). Natural history of cervical human papillomavirus infections. Lancet 357: 1816–1816.
Morris PJ, Dent CL, Ring CJ, Latchman DS . (1993). The octamer-binding site in the HPV 16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res 21: 1019–1023.
Morris PJ, Theil T, Ring CJ, Lillycrop KA, Möröy T, Latchman DS . (1994). The opposite and antagonistic effects of the closely related POU family transcription factors on the activity of a target promoter are dependent upon differences in the POU domain. Mol Cell Biol 14: 6907–6914.
Ndisang D, Budhram-Mahadeo VS, Latchman DS . (1999). Brn-3a transcription factor plays a critical role in regulating human papilloma virus gene expression and determining the growth characteristics of cervical cancer cells. J Biol Chem 274: 28521–28527.
Ndisang D, Budhram-Mahadeo VS, Pedley B, Latchman DS . (2001). The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo. Oncogene 20: 4899–4903.
Ndisang D, Budhram-Mahadeo VS, Singer A, Latchman DS . (2000). Wide-spread elevated expression of the HPV-activating cellular transcription factor Brn-3a in the cervix of women with CIN3. Clin Sci 98: 601–602.
Ndisang D, Lorenzato F, Sindos M, Singer A, Latchman DS . (2006a). Detection of cervical abnormalities in a developing country using measurement of Brn-3a in cervical smears. Gynecol Oncol 100: 89–94.
Ndisang D, Faulkes DJ, Gascoyne D, Lee SA, Ripley BJ, Sindos M et al. (2006b). Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene 25: 51–60.
Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE . (1997). Identification of tobacco specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89: 868–873.
Sindos M, Ndisang D, Pisal N, Chow C, Singer A, Latchman DS . (2003a). Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia. Gynaecol Oncol 90: 366–371.
Sindos M, Ndisang D, Pisal N, Chow C, Deery A, Singer A et al. (2003b). Latchman D. Detection of cervical neoplasia using measurement of Brn-3a in cervical smears with persistent minor abnormalities. J Gynaecol Cancer 13: 515–517.
Tsai YM, Yang SF, Wu KY, Chuang HY, Wu TN, Ho CK et al. (2007). Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm—a community-based control study. Gynaecol Oncol 105: 181–188.
zur Hausen H . (2009). The search for infectious causes of human cancers: where and why. Virology 392: 1–10.
Acknowledgements
This study was funded by the Association for International Cancer Research (AICR).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ndisang, D., Khan, A., Lorenzato, F. et al. The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix. Oncogene 29, 2701–2711 (2010). https://doi.org/10.1038/onc.2010.33
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.33